FACULTY
Respiratory Tract Infections: Focus On Efficacy And Safety Of Current Treatment Options
Paper Symposium
Activity Date: October 2005  — Activity Info: Volume 2, (6)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Directors and Participating Faculty reported the following:

PROGRAM DIRECTORS

Glen E. Farr, PharmD
Professor of Pharmacy
Associate Dean for Continuing Education
University of Tennessee College of Pharmacy
Knoxville, Tennessee
Dr Farr reports serving as a consultant to sanofi-aventis and receiving honoraria from Bristol-Myers Squibb Company and Pfizer Inc.

David P. Nicolau, PharmD, FCCP
Director
Center for Anti-Infective Research and Development
Hartford Hospital
Hartford, Connecticut
Dr Nicolau reports receiving grants/research support and honoraria from Abbott Laboratories, Bayer Pharmaceuticals Corporation, sanofi-aventis, and Schering-Plough Corporation; and serving as a consultant to AstraZeneca LP, Ortho-McNeil Pharmaceutical, Inc, and Wyeth.

PARTICIPATING FACULTY

Richard H. Drew, PharmD, MS, BCPS
Professor
Campbell University  School of Medicine
Buies Creek, North Carolina
Assistant Research Professor, Infectious Diseases
Duke University School of Medicine
Durham, North Carolina
Dr Drew reports serving as a consultant to Schering-Plough Corporation and Wyeth, and serving on the speakers' bureau for Enzon, Inc, sanofi-aventis, and Ortho-McNeil Pharmaceutical,Inc.

Michael B. Kays, PharmD, BCPS, FCCP
Associate Professor of Pharmacy Practice
Purdue University School of Pharmacy and Pharmaceutical Sciences
Indianapolis, Indiana
Dr Kays reports receiving grants/research support from Abbott Laboratories, Bayer
Pharmaceuticals Corporation, Bristol-Myers Squibb Company, GlaxoSmithKline,
Ortho-McNeil Pharmaceutical, Inc, Pfizer Inc, and sanofi-aventis.

Charles W. Stratton, MD
Associate Professor of Medicine and Pathology
Vanderbilt University School of Medicine
Nashville, Tennessee
Dr Stratton reports having no financial or advisory relationships with corporate organizations related to this activity.

Notice: In accordance with the ACPE Criteria for Quality, the audience is advised that articles in this continuing pharmaceutical education activity contains no reference(s) to unlabeled or unapproved uses of drugs or devices.

Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?